伊维菌素、法莫替丁和多西环素：一种用于治疗新冠肺炎的联合治疗建议方案
Ivermectin, Famotidine, and Doxycycline: A Suggested Combinatorial Therapeutic for the Treatment of COVID-19.
作者信息
Sen Gupta Parth Sarthi, Rana Malay Kumar
机构信息
Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Odisha, 760010, India.
出版信息
ACS Pharmacol Transl Sci. 2020 Sep 28;3(5):1037-1038. doi: 10.1021/acsptsci.0c00140. eCollection 2020 Oct 9.
Abstract
At times, combination therapy has proven to be very effective. While no cure is available to date, herein we put forward with rationale and supporting evidence that if administrated simultaneously, a combination of FDA-approved drugs comprising ivermectin, famotidine, and doxycycline may provide robust chemoprophylaxis effective against COVID-19.
摘要
有时，联合疗法已被证明非常有效。虽然迄今为止尚无治愈方法，但在此我们提出理由和支持证据，表明如果同时给药，由伊维菌素、法莫替丁和强力霉素组成的FDA批准药物组合可能提供有效的化学预防，对抗COVID-19。
相似文献
1
Ivermectin, Famotidine, and Doxycycline: A Suggested Combinatorial Therapeutic for the Treatment of COVID-19.伊维菌素、法莫替丁和多西环素：一种用于治疗新冠肺炎的联合治疗建议方案
ACS Pharmacol Transl Sci. 2020 Sep 28;3(5):1037-1038. doi: 10.1021/acsptsci.0c00140. eCollection 2020 Oct 9.
2
Multidrug treatment for COVID-19.COVID-19 的多药治疗。
Drug Discov Ther. 2021 Mar 10;15(1):39-41. doi: 10.5582/ddt.2021.01005. Epub 2021 Feb 19.
3
Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review.伊维菌素和强力霉素联合治疗可有效缓解疫苗接种运动期间 COVID-19 感染的细胞因子风暴：叙述性评论。
J Infect Public Health. 2022 May;15(5):566-572. doi: 10.1016/j.jiph.2022.03.014. Epub 2022 Mar 30.
4
Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment.墨西哥城和梅兹奎塔尔流域 COVID-19 大流行期间的医药废水监测：全面的环境风险评估。
Sci Total Environ. 2023 Nov 20;900:165886. doi: 10.1016/j.scitotenv.2023.165886. Epub 2023 Jul 29.
5
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.局部用伊维菌素10mg/g和口服多西环素40mg缓释剂：抗炎性酒渣鼻治疗联合使用的当前证据
Adv Ther. 2016 Sep;33(9):1481-501. doi: 10.1007/s12325-016-0380-z. Epub 2016 Jul 18.
6
Doxycycline as an inhibitor of p-glycoprotein in the alpaca for the purpose of maintaining avermectins in the CNS during treatment for parelaphostrongylosis.
Vet Parasitol. 2015 Sep 15;212(3-4):303-7. doi: 10.1016/j.vetpar.2015.09.002. Epub 2015 Sep 7.
7
Therapeutic trial of doxycyclin plus ivermectin for the treatment of Brugia malayi naturally infected cats.强力霉素联合伊维菌素治疗自然感染马来布鲁线虫猫的治疗试验
Vet Parasitol. 2017 Oct 15;245:42-47. doi: 10.1016/j.vetpar.2017.08.009. Epub 2017 Aug 18.
8
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.强力霉素加伊维菌素与单用伊维菌素治疗盘尾丝虫病患者的疗效比较
Cochrane Database Syst Rev. 2016 Jan 15;2016(1):CD011146. doi: 10.1002/14651858.CD011146.pub2.
9
Effects of combined drug treatments on Plasmodium falciparum: In vitro assays with doxycycline, ivermectin and efflux pump inhibitors.联合药物治疗对疟原虫的影响：多西环素、伊维菌素和外排泵抑制剂的体外试验。
PLoS One. 2020 Apr 23;15(4):e0232171. doi: 10.1371/journal.pone.0232171. eCollection 2020.
10
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.用不同方案的强力霉素加伊维菌素治疗盘尾丝虫病患者后，对其皮肤中微丝蚴负荷的评估。
Filaria J. 2006 Feb 5;5:1. doi: 10.1186/1475-2883-5-1.
引用本文的文献
1
Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.多西环素在降低 COVID-19 危重症患者血栓形成和死亡率中的潜在作用：一项多中心队列研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231177017. doi: 10.1177/10760296231177017.
2
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?基于细胞和分子生物学的伊维菌素治疗 COVID-19 的更新：它是否有效？
Inflammopharmacology. 2023 Feb;31(1):21-35. doi: 10.1007/s10787-022-01129-1. Epub 2023 Jan 7.
3
Removal of doxycycline hydrochloride from aqueous solution by rice husk ash using response surface methodology and disposability study.采用响应面法和可处置性研究去除水溶液中的盐酸多西环素用稻壳灰。
Environ Sci Pollut Res Int. 2023 Jan;30(4):8485-8499. doi: 10.1007/s11356-022-18961-1. Epub 2022 Feb 14.
4
Integrating heterogeneous data to facilitate COVID-19 drug repurposing.整合异质数据以促进 COVID-19 药物再利用。
Drug Discov Today. 2022 Feb;27(2):558-566. doi: 10.1016/j.drudis.2021.10.002. Epub 2021 Oct 16.
5
Frequency of COVID-19 in acne patients treated with oral doxycycline: A retrospective cross-sectional comparative study.口服多西环素治疗的痤疮患者中新冠病毒病的感染率：一项回顾性横断面比较研究。
J Cosmet Dermatol. 2021 Oct;20(10):3062-3063. doi: 10.1111/jocd.14403. Epub 2021 Aug 20.
6
Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.吸入伊维菌素作为治疗 COVID-19 的重新定位直接药物的安全性：临床前耐受研究。
Int Immunopharmacol. 2021 Oct;99:108004. doi: 10.1016/j.intimp.2021.108004. Epub 2021 Jul 23.
7
Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations.基于固定分子指纹和图卷积神经网络（Graph-CNN）神经表示的机器学习助力鉴定潜在的SARS-CoV-2 3CL蛋白酶抑制剂。
J Biomed Inform. 2021 Jul;119:103821. doi: 10.1016/j.jbi.2021.103821. Epub 2021 May 28.
8
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.序贯多西环素和秋水仙碱联合治疗 COVID-19：有益作用。
Pulm Pharmacol Ther. 2021 Apr;67:102008. doi: 10.1016/j.pupt.2021.102008. Epub 2021 Mar 14.
9
Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease.褪黑素介导的细胞保护及健康与疾病中的信号传导分子机制
Pharmaceutics. 2021 Jan 20;13(2):129. doi: 10.3390/pharmaceutics13020129.
本文引用的文献
1
Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-α with effective drug ivermectin.新型冠状病毒与伊维菌素有效药物的识别蛋白靶标和 Importin-α 的结合机制和结构见解。
J Biomol Struct Dyn. 2022 Mar;40(5):2217-2226. doi: 10.1080/07391102.2020.1839564. Epub 2020 Oct 28.
2
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.使用伊维菌素与 COVID-19 住院患者的死亡率降低相关：COVID-19 中的伊维菌素研究。
Chest. 2021 Jan;159(1):85-92. doi: 10.1016/j.chest.2020.10.009. Epub 2020 Oct 13.
3
Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2.具有临床导向性的药物法莫替丁与鉴定出的 SARS-CoV-2 潜在靶标的结合见解。
J Biomol Struct Dyn. 2021 Sep;39(14):5327-5333. doi: 10.1080/07391102.2020.1784795. Epub 2020 Jun 24.
4
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.法莫替丁的使用与住院COVID-19患者临床结局改善相关：一项倾向评分匹配的回顾性队列研究。
Gastroenterology. 2020 Sep;159(3):1129-1131.e3. doi: 10.1053/j.gastro.2020.05.053. Epub 2020 May 22.
5
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.干扰素 beta-1b、洛匹那韦利托那韦和利巴韦林三联治疗住院 COVID-19 患者：一项开放标签、随机、2 期试验。
Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.
6
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
7
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.肥大细胞在冠状病毒诱导的炎症中起作用：新的抗炎策略。
J Biol Regul Homeost Agents. 2020;34(1):9-14. doi: 10.23812/20-Editorial-Kritas.
8
Inhibitory effect of doxycycline against dengue virus replication in vitro.强力霉素对登革病毒体外复制的抑制作用。
Arch Virol. 2014 Apr;159(4):711-8. doi: 10.1007/s00705-013-1880-7. Epub 2013 Oct 19.
9
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.伊维菌素是一种特异性抑制剂，可以抑制 HIV-1 和登革热病毒的复制，其作用机制为抑制核输入蛋白 importin α/β 介导的核输入。
Biochem J. 2012 May 1;443(3):851-6. doi: 10.1042/BJ20120150.
10
The effect of histamine type 2 receptor antagonists on human immunodeficiency virus (HIV) replication: identification of a new class of antiviral agents.组胺2型受体拮抗剂对人类免疫缺陷病毒（HIV）复制的影响：一类新型抗病毒药物的鉴定。
Life Sci. 1996;59(23):PL 365-70. doi: 10.1016/s0024-3205(96)00553-x.
Zotero 插件